File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

TitleSARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids
Authors
Issue Date16-Apr-2024
PublisherNature Research
Citation
Scientific Reports, 2024, v. 14, n. 1 How to Cite?
Abstract

SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune cell activation and subsequent tissue damage is a significant task. Organoids from human tissues advanced our understanding of SARS-CoV-2 infection mechanisms though, they are missing crucial components: immune cells and endothelial cells. This study aims to generate organoids with these components. We established vascular immune organoids from human pluripotent stem cells and examined the effect of SARS-CoV-2 infection. We demonstrated that infections activated inflammatory macrophages. Notably, the upregulation of interferon signaling supports macrophages’ role in cytokine release syndrome. We propose vascular immune organoids are a useful platform to model and discover factors that ameliorate SARS-CoV-2-mediated cytokine release syndrome.


Persistent Identifierhttp://hdl.handle.net/10722/342792
ISSN
2023 Impact Factor: 3.8
2023 SCImago Journal Rankings: 0.900

 

DC FieldValueLanguage
dc.contributor.authorChau, Chiu Wang-
dc.contributor.authorTo, Alex-
dc.contributor.authorAu-Yeung, Rex K H-
dc.contributor.authorTang, Kaiming-
dc.contributor.authorXiang, Yang-
dc.contributor.authorRuan, Degong-
dc.contributor.authorZhang, Lanlan-
dc.contributor.authorWong, Hera-
dc.contributor.authorZhang, Shihui-
dc.contributor.authorAu, Man Ting-
dc.contributor.authorChung, Seok-
dc.contributor.authorSong, Euijeong-
dc.contributor.authorChoi, Dong-Hee-
dc.contributor.authorLiu, Pentao-
dc.contributor.authorYuan, Shuofeng-
dc.contributor.authorWen, Chunyi-
dc.contributor.authorSugimura, Ryohichi-
dc.date.accessioned2024-04-24T02:47:12Z-
dc.date.available2024-04-24T02:47:12Z-
dc.date.issued2024-04-16-
dc.identifier.citationScientific Reports, 2024, v. 14, n. 1-
dc.identifier.issn2045-2322-
dc.identifier.urihttp://hdl.handle.net/10722/342792-
dc.description.abstract<p>SARS-CoV-2 provokes devastating tissue damage by cytokine release syndrome and leads to multi-organ failure. Modeling the process of immune cell activation and subsequent tissue damage is a significant task. Organoids from human tissues advanced our understanding of SARS-CoV-2 infection mechanisms though, they are missing crucial components: immune cells and endothelial cells. This study aims to generate organoids with these components. We established vascular immune organoids from human pluripotent stem cells and examined the effect of SARS-CoV-2 infection. We demonstrated that infections activated inflammatory macrophages. Notably, the upregulation of interferon signaling supports macrophages’ role in cytokine release syndrome. We propose vascular immune organoids are a useful platform to model and discover factors that ameliorate SARS-CoV-2-mediated cytokine release syndrome.</p>-
dc.languageeng-
dc.publisherNature Research-
dc.relation.ispartofScientific Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleSARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids-
dc.typeArticle-
dc.identifier.doi10.1038/s41598-024-59405-9-
dc.identifier.scopuseid_2-s2.0-85190529269-
dc.identifier.volume14-
dc.identifier.issue1-
dc.identifier.eissn2045-2322-
dc.identifier.issnl2045-2322-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats